Non-Lactational Mastitis: Diagnosis and Treatment
Critical First Step: Rule Out Inflammatory Breast Cancer
The most important initial action is to exclude inflammatory breast cancer, particularly if symptoms fail to respond to at least 1 week of antibiotics or if the patient presents with rapid onset (<6 months) of erythema covering at least one-third of the breast. 1
Red Flags Requiring Immediate Biopsy:
- Mastitis not responding to 1 week of antibiotics 1
- Erythema occupying ≥1/3 of the breast with symptom duration <6 months 1
- Presence of peau d'orange, edema, or skin dimpling 1
- Age ≥45 years with persistent symptoms 1
- Asymmetry compared to contralateral breast or attachment to deep fascia 1
Core needle biopsy or skin punch biopsy is mandatory when any of these features are present to confirm or exclude malignancy. 1
Diagnostic Workup Algorithm
Physical Examination Essentials:
- Assess for three-dimensional masses distinct from surrounding tissue 1
- Check for skin dimpling, attachment to deep fascia, or nipple retraction 1
- Evaluate extent of erythema or hyperpigmentation 1
- Document focal breast sensitivity 1
Imaging Indications:
- Ultrasound is indicated for: immunocompromised patients, worsening or recurrent symptoms, or suspected abscess (occurs in ~10% of cases) 1
- Mammography should be considered based on age and risk factors, though its role in mastitis diagnosis is limited 1
Etiologic Categories of Non-Lactational Mastitis
Based on systematic review data, bacterial causes account for 84.8% of cases: 2
- Mycobacterium tuberculosis (38.4% of bacterial cases) 2
- Corynebacterium species (20.5% of bacterial cases) 2
- Non-tuberculous mycobacteria (17.8% of bacterial cases) 2
- Streptococcus/Pseudomonas and Staphylococcus aureus are also common 3
Special Consideration: MDAIDS (Mammary Ducts Associated Inflammatory Diseases Sequence)
- Characterized by duct ectasia, squamous metaplasia, and lymphoid infiltration 3
- Strongly correlated with heavy smoking 3
- May require surgical treatment for definitive diagnosis 3
Treatment Approach
For Infectious Non-Lactational Mastitis:
1. Initial Antibiotic Therapy:
- Start empiric antibiotics covering Staphylococcus and Streptococcus species 2, 3
- If no improvement after 1 week, immediately pursue biopsy to exclude malignancy 1
2. Surgical Management:
- Incision and drainage for abscesses 3
- Timely debridement with manual compression to drain exudate from sinus wounds 4
- Excision may be necessary for definitive diagnosis and treatment 3
- Modern wound dressings should be selected for sinus tract drainage and infection control 4
3. Special Pathogen Considerations:
- If tuberculosis or non-tuberculous mycobacteria suspected (particularly in endemic areas or immunocompromised patients), obtain tissue for culture and acid-fast staining 2
- Corynebacterium infections may require prolonged antibiotic therapy 2
For Intertrigo (Inframammary Fold Infection):
Moisture control is the single most important intervention—failure to keep the area dry will cause treatment failure. 5
- First-line: Topical azoles (clotrimazole, miconazole) or polyenes (nystatin) for candidal intertrigo 5
- If erythema persists after 1 week of antifungal treatment, add antibiotics for secondary bacterial infection 5
- For inverse psoriasis mimicking intertrigo: use low-potency topical corticosteroids only (high-potency agents cause skin atrophy in occluded areas) 5
- Absence of satellite pustules suggests psoriasis rather than candidal infection 5
Critical Pitfalls to Avoid
- Never continue antibiotics beyond 1 week without clinical improvement—obtain biopsy immediately 1, 5
- Never use high-potency corticosteroids in breast folds due to increased systemic absorption and skin atrophy risk 5
- Never rely solely on topical therapy for intertrigo without addressing moisture control 5
- Never delay biopsy in patients ≥45 years with persistent symptoms, as this age group is at risk for inflammatory breast carcinoma 1
- Never perform breast-conserving surgery if inflammatory breast cancer is diagnosed—only modified radical mastectomy is acceptable 6